Levi &Korsinsky, LLP notifies investors in Open Lending Corporation (“Open Lending Corporation” or the “Company”) (NASDAQ: LPRO) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Open Lending Corporation investors who were adversely affected by alleged securities fraud between February 24, 2022 and March 31, 2025. […]

Levi &Korsinsky, LLP notifies investors in Avis Budget Group, Inc. (“Avis Budget” or the “Company”) (NASDAQ: CAR) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Avis Budget investors who were adversely affected by alleged securities fraud between February 16, 2024 and February 10, 2025. Follow

Levi & Korsinsky, LLP notifies investors in Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Napco investors who were adversely affected by alleged securities fraud between February 5, 2024 and February 3, 2025. Follow the

Levi & Korsinsky, LLP notifies investors in NET Power, Inc. (“NET Power, Inc.” or the “Company”) (NYSE: NPWR) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of NET Power, Inc. investors who were adversely affected by alleged securities fraud between June 9, 2023 and March 7,

Levi & Korsinsky, LLP notifies investors in Zenas BioPharma, Inc. (“Zenas BioPharma, Inc.” or the “Company”) (NASDAQ: ZBIO) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Zenas BioPharma, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons

Levi &Korsinsky, LLP notifies investors in Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ibotta investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons or entities who purchased or otherwise

Levi & Korsinsky, LLP notifies investors in BigBear.ai Holdings, Inc. (“BigBear.ai Holdings” or the “Company”) (NYSE: BBAI) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BigBear.ai Holdings investors who were adversely affected by alleged securities fraud between March 31, 2022 and March 25, 2025. Follow

Levi &Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. (“Treace Medical Concepts, Inc.” or the “Company”) (NASDAQ: TMCI) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and

Levi &Korsinsky, LLP notifies investors in Viatris Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Viatris investors who were adversely affected by alleged securities fraud between August 8, 2024 and February 26, 2025. Follow the link below to

Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. (“Cerevel Therapeutics Holdings, Inc.” or the “Company”) (NYSE: ABBV) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cerevel Therapeutics Holdings, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on